Ownership history in PUZO MICHAEL J · 16 quarters on record
This page tracks every 13F SEC filing in which PUZO MICHAEL J reported a position in VERTEX PHARMACEUTICALS (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 15,371 | -130 | -0.8% | 1.90% | $7.0M | $453.36 |
| 2025 Q3 | ADDED | 15,501 | +161 | +1.0% | 1.66% | $6.1M | $391.64 |
| 2025 Q2 | ADDED | 15,340 | +55 | +0.4% | 1.95% | $6.8M | $445.20 |
| 2025 Q1 | ADDED | 15,285 | +1,176 | +8.3% | 2.12% | $7.4M | $484.82 |
| 2024 Q4 | ADDED | 14,109 | +1,872 | +15.3% | 1.59% | $5.7M | $402.70 |
| 2024 Q3 | ADDED | 12,237 | +2,671 | +27.9% | 1.49% | $5.7M | $465.08 |
| 2024 Q2 | ADDED | 9,566 | +4,953 | +107.4% | 1.24% | $4.5M | $468.72 |
| 2024 Q1 | ADDED | 4,613 | +3,763 | +442.7% | 0.53% | $1.9M | $418.01 |
| 2023 Q4 | REDUCED | 850 | -1,900 | -69.1% | 0.11% | $346K | $406.89 |
| 2019 Q3 | UNCHANGED | 2,750 | — | 0% | 0.18% | $466K | $169.42 |
As of 2025 Q4 — sorted by position size